Overall Technical outlook

Price Summary

On 2025-12-15, Alembic Pharmaceuticals Limited's stock opened at 875.8, reached a high of 878.85, dropped to a low of 862.95, and closed lower -1.27% at 864.7, with a trading volume of 59576 shares.
Over the past year, the stock's highest price was 1091.5, and its lowest was 743.65.
12 analysts forecast that the price of APLLTD will range from 895.0 to 1275.0, with an average expected price near 1055.25.

Technicals


Aroon: The current state of the AROON is neutral for APLLTD, providing no clear indication of a trend in either direction. This suggests that the market may be lacking momentum, making it difficult to predict future movements.
APLLTD aroon 53f646
Aroon chart for Alembic Pharmaceuticals Limited


Bol. Bands: The price has crossed below the lower Bollinger Band, indicating a potential oversold condition in the market. This downward movement suggests that selling pressure has been strong enough to push prices below a critical support level. While the breach could mean the bearish trend will continue, it also raises the possibility of a reversal if buyers step in at these lower levels.
APLLTD bbands 53f646
Bolinger Bands chart for Alembic Pharmaceuticals Limited


Parabolic SAR: The PSAR for APLLTD remains bearish, establishing a key resistance level that could hinder upward movement. This ongoing bearish outlook suggests that the market may face challenges in breaking higher, with the resistance level acting as a barrier to potential gains.
APLLTD psar 53f646
Parabolic Stop and Reverse chart for Alembic Pharmaceuticals Limited


Stochastic: The current reading of the STOCHASTIC is neutral for APLLTD, with no clear signals for an upward or downward trend. This indicates that the market may be in a state of uncertainty, with no dominant force driving the direction.
APLLTD stoch 53f646
Stochastic chart for Alembic Pharmaceuticals Limited


Tripple Moving Agerage: A bullish trend for Alembic Pharmaceuticals Limited is reflected in the alignment of the 20-50-100 period moving averages, though the slopes of the faster averages raise concerns about a potential reversal. The weakening momentum in the shorter-term averages suggests that the current trend may not last, signaling the possibility of a shift in direction.
APLLTD trippleSMA 53f646
Tripple SMA chart for Alembic Pharmaceuticals Limited


Analyzing the technical indicators of a company, such as stock price and trading volume, requires first understanding its fundamentals. These fundamentals include profitability, growth potential, and market position. Furthermore, knowing the broader industry trends and competitive landscape provides critical context. When both the company's internal data and the external environment are considered, it allows for more meaningful conclusions about the company's technical performance and future trajectory.